[ad_1]
This “Global Pharmaceutical Packaging Growth Opportunities” report added to ResearchAndMarkets.com’s supply.
The COVID-19 pandemic has exposed not only the challenges of supply chains in meeting the demand caused by the pandemic, but also the vulnerability of facing disruptions on a global scale. Immediate impacts include supply volatility, sharp price increases and high levels of uncertainty.
Supply chain disruptions have had knock-on effects despite the restart of manufacturing. In addition, the lack of time stamping and poor traceability of pharmaceutical chain of custody throughout the supply chain shortens the shelf life of existing inventory and increases the risks associated with waste.
With the FDA approval of the Pfizer-BioNTech vaccine, the arrival of the Moderna and Johnson & Johnson vaccines in patients under Emergency Use Authorization (EUA), and the authorization of booster doses, an exemplary supply chain is required, and it must…
The full story is available on Benzinga.com
[ad_2]
Source link
